NCT04147221View on ClinicalTrials.gov

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

September 10, 2021

Study Completion Date

September 19, 2021

Conditions
Sepsis
Interventions
DRUG

Imipenem-relebactam

After receipt of imipenem-relebactam, participants will have six blood samples collected over 6 hours for determination of imipenem and relebactam concentrations.

Trial Locations (1)

06102

Hartford Hospital, Hartford

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Hartford Hospital

OTHER

NCT04147221 - Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance | Biotech Hunter | Biotech Hunter